News
NHS chief hails SMA drug deal - and was that a swipe at Vert...
Children in England with the rare muscle wasting disease spinal muscular atrophy (SMA) will get access to Biogen’s super-expensive new drug Spinraza after the manufacturer struck a deal wit
